openPR Logo
Press release

Combination Antibody Therapy Market to Extent an Assessed Value of US$ 144,734.5 Million by 2024

03-06-2018 08:06 AM CET | Health & Medicine

Press release from: Persistence Market Research

Combination Antibody Therapy Market to Extent an Assessed Value

Higher success ratio in treating and preventing cancer cells using combination antibody therapy is fuelling the demand for combination antibody drugs in the market. A study conducted by Persistence Market Research (PMR) shows that the global market for combination antibody therapy is set to ride on a value CAGR of over 14% during the period of assessment to reach US$ 144,734.5 Million by 2024 end. In 2016, the global market was valued at over US$ 49,994 Million characterizing the overwhelming popularity of antibody/antibody drugs amongst both practitioners and patients observed in recent years.

Combination Antibody Therapy Market Research Report Overview @ https://www.persistencemarketresearch.com/market-research/combination-antibody-therapy-market.asp

Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination antibody drugs are actively focusing on developing superior drugs that will deliver standout results. Factors such as encouraging government policies, growing concerns over higher cancer prevalence worldwide, and increasing research and development activities coupled with heavier investments are expected to boost the overall market growth in the near future. Likewise, healthy R&D pipelines are leading towards higher product offerings and also propelling the growth of global combination antibody therapy market to a significant extent.

The prolonged attrition rate in product development cycle and arbitrary and stringent drug approval procedures are the major downsides of the market that are likely to inhibit the market growth during the forecast period. Moreover, lack of awareness on understanding the difference between immunotherapies and chemotherapies amongst healthcare professionals, which is restricting the optimal use of immunotherapies alongside conventional treatment modalities is an additional factor impeding the market growth. Further, late diagnosis or ignorance of any carcinogenic disorders may inevitably lead to higher cost of treatment.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/11740

Based on combinations, antibody/antibody is projected to be the predominant segment of the market over the forecast period. In terms of revenue, the segment is expected to witness a healthy CAGR of over 17% between 2016 and 2024. The growth is attributed to the increasing preference of antibody/antibody drugs as they have a lower risk of side effects for various cancer therapies. Whereas, the chemotherapy/antibody segment will hold the second position, accounting for 38.3% share of the market in 2016.

Demand for combination antibody therapy will be high for breast cancer and lung cancer treatment on the basis of applications. The lung cancer segment is anticipated to expand at a value CAGR of 17.1% during the assessment period.By end user, hospitals are expected to be the largest segment of the market throughout the forecast period. In 2015, the segment was valued at US$ 26,906.5 Million, which is expected to surpass US$ 95,885 Million by 2024 end, reflecting a CAGR of 15.2%.

From a regional perspective, North America will continue to be the leading market for combination antibody therapy over the forecast period. In addition, the region is set to witness a CAGR of over 13% in terms of value. Whereas, APAC is expected to reflect the fastest growth of the market during the forecast period in terms of value. Further, the market in the region is estimated to witness a 3.4X growth in terms of sales over 2024 owing to increasing prevalence of carcinogenic disorders in APAC.

Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/checkout/11740

Key participants functioning in the global market for combination antibody therapy include Roche Holdings AG, Amgen Incorporated, Novartis AG, Celgene Corporation, Biogen Inc., Seattle Genetics Inc., Genmab A/S, Bristol-Myers Squibb Company, Eli-Lilliy and Company and Sanofi.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Combination Antibody Therapy Market to Extent an Assessed Value of US$ 144,734.5 Million by 2024 here

News-ID: 965593 • Views:

More Releases from Persistence Market Research

Advanced Functional Materials Market to Surpass US$ 210.4 Bn by 2032 Driven by Rapid Adoption Across High-Tech Industries
Advanced Functional Materials Market to Surpass US$ 210.4 Bn by 2032 Driven by R …
➤Overview of the Market According to the latest study by Persistence Market Research, the global advanced functional materials market is valued at US$ 135.2 Bn in 2025 and is projected to reach US$ 210.4 Bn by 2032, expanding at a robust CAGR of 6.5%. The rising demand for lightweight, high-performance, and energy-efficient materials across electronics, automotive, aerospace, and renewable energy sectors is fueling sustained growth for these next-generation materials. The advanced functional
P-Tert-Butylphenol Market to Reach US$2.0 Bn by 2032 Fueled by Rising Demand in Adhesives and Resins
P-Tert-Butylphenol Market to Reach US$2.0 Bn by 2032 Fueled by Rising Demand in …
➤ Overview of the Market According to the latest study by Persistence Market Research, the global P-tert-butylphenol (PTBP) market is projected to grow from US$1.5 Bn in 2025 to US$2.0 Bn by 2032, expanding at a CAGR of 4.0%. Increasing adoption of PTBP in the production of synthetic resins, coatings, and adhesives, alongside growing consumption in the rubber and plastics industries, is driving consistent market growth. Its unique chemical properties, such
U.S. Non-Destructive Testing Market to Reach USD 9.2 Billion by 2032, Registering an 8.9% CAGR (2025-2032)
U.S. Non-Destructive Testing Market to Reach USD 9.2 Billion by 2032, Registerin …
The U.S. non-destructive testing (NDT) market is experiencing rapid growth, fueled by rising infrastructure maintenance needs and technological advancements. The market is projected to reach a value of US$ 5 billion in 2025 and is expected to surge to US$ 9.2 billion by 2032, recording a robust CAGR of 8.9% during the forecast period. NDT plays a critical role in assessing the safety and reliability of aging infrastructure, including bridges,
U.S. Video-based Automatic Incident Detection Market to Reach USD 1,650.39 Million by 2032, Registering a 14.5% CAGR (2025-2032)
U.S. Video-based Automatic Incident Detection Market to Reach USD 1,650.39 Milli …
The U.S. video-based automatic incident detection (AID) market is witnessing rapid growth, driven by technological advancements and increasing adoption of intelligent traffic management systems. This market is projected to expand from US$ 657.2 million in 2025 to US$ 1,650.39 million by 2032, recording a robust CAGR of 14.5% over the forecast period. Key drivers include the rising integration of artificial intelligence (AI) and machine learning (ML) in video analytics, which

All 5 Releases


More Releases for CAGR

[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends. Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064 According to the report published by Allied Market Research,
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032. This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks
[CAGR of 5.5%] Silica Flour Market Size, CAGR, Competitive Analysis and Forecast …
The global silica flour industry generated $520.0 million in 2021, and is estimated to reach $876.3 million by 2031, witnessing a CAGR of 5.5% from 2022 to 2031. Allied Market Research published a report, titled, "Silica Flour Market by Type (Quartz, Cristobalite), by Application (Fiberglass, Glass and Clay, Oil Well Cement, Ceramic and Refractory, Foundry, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." The report offers a detailed analysis
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial
Call Center AI Market Latest, CAGR, Volume and Value 2022-2030 | (CAGR) of 25%
New York , United States- Report Ocean published the latest research report on the Call Center AI market. In order to comprehend a market holistically, a variety of factors must be evaluated, including demographics, business cycles, and microeconomic requirements that pertain precisely to the market under study. In addition, the Call Center AI market study demonstrates a detailed examination of the business state, which represents creative ways for company growth,